Guidance

Hepatitis A vaccine: patient group direction (PGD) template

PGD template to support the provision of hepatitis A vaccine to individuals pre- and post-exposure to hepatitis A.

• From: UK Health Security Agency
• Published: 13 November 2017
• Last updated: 10 October 2023 — See all updates

Applies to England

Documents

Hepatitis A vaccine: patient group direction template

Ref: UKHSA publications gateway number GOV-15398

MS Word Document, 166 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Hepatitis A vaccine patient group direction (PGD) version 5.00 is valid from 31 October 2023 to 31 October 2026.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 13 November 2017
Last updated 10 October 2023 + show all updates

1. 10 October 2023

   Added version 5.00 – see page 2 for change history.

2. 15 October 2021

   Added v04.00.

3. 14 October 2019

   Added template V03.00 which includes information regarding MSM and amended review date.

4. 30 September 2019

   Added template V02.00.

5. 13 November 2017

   First published.